Safety and Feasibility Evaluation of ALVIV Laser Based Treatment for Fecal Incontinence
Recruiting
N/A
Interventional Study
Fecal Incontinence (FI)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 12 (estimated)
- Sponsor
- Alviv Ltd. · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose if this interventional First in Human study is to assess the Safety and Performance of the ALVIV System laser based treatment in patients diagnosed with Fecal Incontinence.
Eligible patients will go through screening assessments, followed by a series of 4-6 treatments with 3 weeks apart. Last follow up visit to the study will occur 3 weeks after last treatment day.
Participants will …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Onset of symptoms for uncontrolled passage of fecal material for at least 6 months prior to enrollment.
* At least 2-4 staining, solid or liquid FI episodes in the 4 weeks prior to enrollment
* Documented normal colonoscopy in the last 3 years
* Normal sigmoidoscopy as part of…
Contacts